The Effect of Bevacizumab on Vestibular Schwannoma Related to Neurofibromatosis Type 2
, , , , , , , , , , und | 01. Mai 2021
Über diesen Artikel
Article Category: research-article
Online veröffentlicht: 01. Mai 2021
Seitenbereich: 5 - 14
DOI: https://doi.org/10.21307/ajon-2021-002
Schlüsselwörter
© 2021 Simone Ardern-Holmes et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1:
Figure 2:
Results Summary for Tumour Volume and Audiometry Response
| Patient | Age (years) | Unilateral or Bilateral Tumour | Duration of Treatment (months) | Baseline Total Tumour Volume (cm3) | Best Volume Response % (response) | Best Hearing Response (right/left ear) |
|---|---|---|---|---|---|---|
| 1 | 22 | U | 27 | 10.79 | -53 (PR | R: PR, L: not tested |
| 2 | 23 | B | 24 | 5.55 | -21 (PR) | R: SD |
| 3 | 33 | B | 12 | 16.26 | -32 (PR) | R: PD, L: PD |
| 4 | 22 | B | 9 | 18.51 | -37 (PR) | R: PR, L: SD |
| 5 | 31 | B | 9 | 38.51 | -28 (PR) | R: not tested, L: NA |
| 6 | 33 | B | 15 | 3.76 | -25 (PR) | R: SD, L: SD |
| 7 | 13 | B | 9 | 1.77 | +17 (SD) | R: SD, L: not tested |
| 8 | 15 | B | 47 | 1.45 | +241 (PD) | R: NA |
| 9 | 14 | B | 9 | 13.38 | +14 (SD) | R: SD, L: SD |
| 10 | 67 | B | 9 | 4.25 | -57 (PR) | R: SD, L: SD |
| 11 | 17 | B | 18 | 37.9 | +30 (PD) | R: SD then PD, L: PR then PD |
| Mean: | 26 | 17 | 14.17 | +4.45 | +2.5 (decibels) |